Literature DB >> 11427538

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells.

T Kimura1, K Sato, A Kuwabara, H Tomura, M Ishiwara, I Kobayashi, M Ui, F Okajima.   

Abstract

Sphingosine 1-phosphate (S1P), a novel lipid mediator, is concentrated in the fraction of lipoproteins that include high density lipoprotein (HDL) and low density lipoprotein (LDL) in human plasma. Here, we show that oxidation of LDL resulted in a marked reduction in the S1P level in association with a marked accumulation of lysophosphatidylcholine (LPC). We therefore investigated the role of the lipoprotein-associated lipids especially S1P in the lipoprotein-induced cytoprotective or cytotoxic actions in human umbilical vein endothelial cells. The viability of the cells gradually decreased in the absence of serum or growth factors in the culture medium. The addition of oxidized LDL (ox-LDL) accelerated the decrease in the cell viability. LPC and 7-ketocholesterol mimicked ox-LDL actions. On the other hand, HDL and LDL almost completely reversed the serum deprivation- or ox-LDL-induced cytotoxicity. Exogenous S1P mimicked cytoprotective actions. Moreover, the S1P-rich fraction and chromatographically purified S1P from HDL exerted cytoprotective actions, but the rest of the fractions did not. The cytoprotective actions of HDL and S1P were associated with extracellular signal-regulated kinase (ERK) activation and were almost completely inhibited by pertussis toxin and PD98059, an ERK kinase inhibitor. The HDL-induced action was specifically desensitized in the S1P-pretreated cells. Taken together, these results indicate that the lipoprotein-associated S1P and the lipid receptor-mediated signal pathways may be responsible for the lipoprotein-induced cytoprotective actions. Furthermore, the decrease in the S1P content, in addition to the accumulation of cytotoxic substances such as LPC, may be important for the acquisition of the cytotoxic property to ox-LDL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427538     DOI: 10.1074/jbc.M104353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

3.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

4.  Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.

Authors:  J Igarashi; M Miyoshi; T Hashimoto; Y Kubota; H Kosaka
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

Review 5.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

6.  High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.

Authors:  Rong Tao; Holly E Hoover; Norman Honbo; Mikaila Kalinowski; Conrad C Alano; Joel S Karliner; Robert Raffai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

Review 7.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 8.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

9.  Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.

Authors:  Takao Kimura; Hideaki Tomura; Koichi Sato; Masaaki Ito; Isao Matsuoka; Doon-Soon Im; Atsushi Kuwabara; Chihiro Mogi; Hiroshi Itoh; Hitoshi Kurose; Masami Murakami; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

10.  Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival.

Authors:  Johnny H Chen; Maziar Riazy; Shih Wei Wang; Jiazhen Minnie Dai; Vincent Duronio; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.